ILA 31.3% 10.5¢ island pharmaceuticals limited

Ann: Phase 2a/b clinical trial update, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 87 Posts.
    lightbulb Created with Sketch. 33
    I think they have enough cash to get through to the new year and if they get good results In the first half of the trial the options will be converted allowing ILA to get through to the end of the full trial to then do a cap raise at a much higher MC. Once they are in a better cash position they can then partner up for the next phase.

    Just my thoughts.....
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.